These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7833133)

  • 1. Dysplasia in normal-looking urothelium increases the risk of tumour progression in primary superficial bladder cancer.
    Kiemeney LA; Witjes JA; Heijbroek RP; Debruyne FM; Verbeek AL
    Eur J Cancer; 1994; 30A(11):1621-5. PubMed ID: 7833133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Should random urothelial biopsies be taken from patients with primary superficial bladder cancer? A decision analysis. Members of the Dutch South-East Co-Operative Urological Group.
    Kiemeney LA; Witjes JA; Heijbroek RP; Koper NP; Verbeek AL; Debruyne FM
    Br J Urol; 1994 Feb; 73(2):164-71. PubMed ID: 8131019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical significance of urothelial dysplasia concomitant with superficial bladder cancer].
    Ishii T; Takeuchi F; Hiratsuka Y; Ariyoshi A
    Nihon Hinyokika Gakkai Zasshi; 1999 Jun; 90(6):633-8. PubMed ID: 10422439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The significance of bladder quadrant biopsies in patients with primary superficial bladder carcinoma.
    Flamm J; Dona S
    Eur Urol; 1989; 16(2):81-5. PubMed ID: 2714336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical evaluation of random biopsy of urinary bladder in patients with superficial bladder cancer.
    Taguchi I; Gohji K; Hara I; Gotoh A; Yamada Y; Yamanaka K; Okada H; Arakawa S; Kamidono S
    Int J Urol; 1998 Jan; 5(1):30-4. PubMed ID: 9535597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Significance of random biopsies of healthy mucosa in superficial bladder tumor].
    Fernández Gómez JM; Rodríguez Martínez JJ; Escaf Barmadah S; Pérez García J; García J; Casasola Chamorro J
    Arch Esp Urol; 2000 Nov; 53(9):785-97. PubMed ID: 11196385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictability of recurrent and progressive disease in individual patients with primary superficial bladder cancer.
    Kiemeney LA; Witjes JA; Heijbroek RP; Verbeek AL; Debruyne FM
    J Urol; 1993 Jul; 150(1):60-4. PubMed ID: 8510276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of factors predicting intravesical recurrence of superficial transitional cell carcinoma of the bladder without concomitant carcinoma in situ.
    Sakai I; Miyake H; Harada K; Hara I; Inoue TA; Fujisawa M
    Int J Urol; 2006 Nov; 13(11):1389-92. PubMed ID: 17083389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The significance of urothelial dysplasia as diagnosed by cup biopsies.
    Harewood LM
    Aust N Z J Surg; 1986 Mar; 56(3):199-203. PubMed ID: 3459428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of random mucosal biopsies in the management of superficial bladder cancer.
    Mufti GR; Singh M
    Eur Urol; 1992; 22(4):288-93. PubMed ID: 1490505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of biopsy results of normal-looking mucosa in cases of superficial bladder cancer.
    Smith G; Elton RA; Beynon LL; Newsam JE; Chisholm GD; Hargreave TB
    Br J Urol; 1983 Dec; 55(6):665-9. PubMed ID: 6652436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors affecting recurrence and progression in superficial bladder tumours.
    Kurth KH; Denis L; Bouffioux C; Sylvester R; Debruyne FM; Pavone-Macaluso M; Oosterlinck W
    Eur J Cancer; 1995 Oct; 31A(11):1840-6. PubMed ID: 8541110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Studies on multiple mucosal biopsy in patients with bladder cancer. 1. Evaluation of the results of multiple mucosal biopsy in patients with bladder cancer and in vivo methylene blue staining].
    Igawa M
    Hinyokika Kiyo; 1986 Nov; 32(11):1617-31. PubMed ID: 2435127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can re-cTURBT be useful in pT1HG disease as a risk indicator of recurrence and progression? A single centre experience.
    Giulianelli R; Gentile BC; Mirabile G; Albanesi L; Tariciotti P; Rizzo G; Buscarini M; Vermiglio M
    Arch Ital Urol Androl; 2017 Dec; 89(4):272-276. PubMed ID: 29473376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of the time period between diagnosis of muscle invasion and radical cystectomy with regard to the prognosis of transitional cell carcinoma of the urothelium in the bladder.
    May M; Nitzke T; Helke C; Vogler H; Hoschke B
    Scand J Urol Nephrol; 2004; 38(3):231-5. PubMed ID: 15204377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumour location adjacent to the ureteric orifice in primary Ta/T1 bladder cancer is predictive of recurrence.
    Jancke G; Rosell J; Jahnson S
    Scand J Urol; 2016; 50(1):33-8. PubMed ID: 26202687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple biopsies of normal-looking urothelium in patients with superficial bladder cancer: Are they necessary?
    Fujimoto N; Harada S; Terado M; Sato H; Matsumoto T
    Int J Urol; 2003 Dec; 10(12):631-5. PubMed ID: 14633065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for local recurrence in patients with pTa/pT1 urinary bladder cancer.
    Jancke G; Damm O; Rosell J; Jahnson S
    Scand J Urol Nephrol; 2008; 42(5):417-21. PubMed ID: 18609266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognostic significance of dysplastic urothelial changes for the rate of recurrence in superficial urinary bladder cancer].
    Flamm J
    Z Urol Nephrol; 1987 Nov; 80(11):641-6. PubMed ID: 3439374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors for primary superficial transitional cell carcinoma of the bladder: a retrospective cohort study.
    Yang TB; Zeng FH; Sun ZQ
    Chin Med J (Engl); 2006 Nov; 119(21):1821-8. PubMed ID: 17097038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.